QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=DBD095BCCA38433041347AA587F55A81;jsessionid=A1E308CF1FD395834B52B6503334BEEC;jsessionid=F2FC8EFD593F9A16E66F616FE41E66CE;jsessionid=058760CF5BFDB1B7EDF27911D4801CD5;jsessionid=F0EBCCD9EFB30CCFC627E31CF47010FA;jsessionid=C0386A51017EFCC090264BFE259ACA32;jsessionid=EC0B3A52A9C010DB91C4C78E539F11B5;jsessionid=6B17DF1AB307027FD37B31A86935B57E;jsessionid=3FBE83D7882A0C453B778682624BAE7E;jsessionid=28DF3AD0A3BE2011F85A69A904741583;jsessionid=7A4459CC3DAB7C0D3B18A519A4626FED;jsessionid=653FB4B610E1CD9F68FC5AFA842FF89B;jsessionid=6AF0FEF506F58D1192F3A8AA4A27330B;jsessionid=DAB477C8D0D7D9B9B92CB29BE8CD85AC;jsessionid=3E13A630C7966DFA1B467263EF83BC80;jsessionid=14404CD620F33987B391AA5AC99265AE;jsessionid=0ACF87B57A1BE7F0E4C83043129664ED;jsessionid=93603D9A2FB01C0E22C7A519BB994A33;jsessionid=9A99D0B7223C78B50C5A467223190D0D (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=DBD095BCCA38433041347AA587F55A81;jsessionid=A1E308CF1FD395834B52B6503334BEEC;jsessionid=F2FC8EFD593F9A16E66F616FE41E66CE;jsessionid=058760CF5BFDB1B7EDF27911D4801CD5;jsessionid=F0EBCCD9EFB30CCFC627E31CF47010FA;jsessionid=C0386A51017EFCC090264BFE259ACA32;jsessionid=EC0B3A52A9C010DB91C4C78E539F11B5;jsessionid=6B17DF1AB307027FD37B31A86935B57E;jsessionid=3FBE83D7882A0C453B778682624BAE7E;jsessionid=28DF3AD0A3BE2011F85A69A904741583;jsessionid=7A4459CC3DAB7C0D3B18A519A4626FED;jsessionid=653FB4B610E1CD9F68FC5AFA842FF89B;jsessionid=6AF0FEF506F58D1192F3A8AA4A27330B;jsessionid=DAB477C8D0D7D9B9B92CB29BE8CD85AC;jsessionid=3E13A630C7966DFA1B467263EF83BC80;jsessionid=14404CD620F33987B391AA5AC99265AE;jsessionid=0ACF87B57A1BE7F0E4C83043129664ED;jsessionid=93603D9A2FB01C0E22C7A519BB994A33;jsessionid=9A99D0B7223C78B50C5A467223190D0D